🇺🇸 FDA
Patent

US 10350183

Intravenous baclofen formulations and treatment methods

granted A61KA61K31/197A61K45/06

Quick answer

US patent 10350183 (Intravenous baclofen formulations and treatment methods) held by Regents of the University of Minnesota expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/197, A61K45/06, A61K9/0019, A61P